368 filings
Page 4 of 19
8-K
bem 4r1ild
10 Aug 23
Avenue Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:20pm
8-K
hqo7zkz9 q4w1ww2
21 Jul 23
Other Events
4:37pm
8-K
dnd q0rv7tmzczc9ole
5 Jul 23
Departure of Directors or Certain Officers
4:15pm
4
np0yhyt2sk5hwcsd92g
5 Jul 23
AVENUE THERAPEUTICS / Faith L. Charles ownership change
4:10pm
4
uocuvt x85
5 Jul 23
AVENUE THERAPEUTICS / David Jin ownership change
4:09pm
4
d7dtqu5x5uq481m
5 Jul 23
AVENUE THERAPEUTICS / LINDSAY A MD ROSENWALD ownership change
4:08pm
4
y3lw39wcgv3xwpy
5 Jul 23
AVENUE THERAPEUTICS / JAY D KRANZLER ownership change
4:08pm
4
ydvsnf
5 Jul 23
AVENUE THERAPEUTICS / Curtis Gale Oltmans ownership change
4:07pm
4
51l24aufi4h
5 Jul 23
AVENUE THERAPEUTICS / Neil Herskowitz ownership change
4:07pm
4
gndqh3mpepo0aadfi
3 Jul 23
AVENUE THERAPEUTICS / Alexandra MacLean ownership change
1:05pm
424B3
ub256tuih3xh2jgf7f
28 Jun 23
Prospectus supplement
4:56pm
EFFECT
bclpwn5d3o8nn3
28 Jun 23
Notice of effectiveness
12:15am
8-K
tlkw6y9 2noiehib
26 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
CORRESP
ruqkvmeyr o3vx7dm7
23 Jun 23
Correspondence with SEC
12:00am
UPLOAD
rkqm19aav0w8mrz
22 Jun 23
Letter from SEC
12:00am
8-K
cnju87jc7za65pxb
22 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
jwiovbwurmbplpi
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
424B3
gsxiluz3vjokc
4 May 23
Prospectus supplement
4:30pm